A recent CNN article contained good news for people who prefer not to have swabs inserted deep into their nostrils. The FDA has granted emergency use authorization for a COVID-19 breath test. The diagnostic tool identifies chemical compounds associated with the virus in breath, and can be used in medical offices and mobile testing sites. The test is called the InspectIR Covid-19 Breathalyzer, and it detects five compounds associated with SARS-CoV-2 infections. A study on the device found that it was able to accurately identify 91% of positive samples, and virtually 100% of negative samples. A video with more information can be seen here. Finally, a breathalyzer I wouldn’t mind taking!
FDA Clears First COVID-19 Breath Test
Move over painful swabs, now we have a breathalyzer that identifies compounds associated with SARS-CoV-2 infections.
Apr 22, 2022
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Downloads



















